Key Takeaways
- • North American insurers' median allocation to private equity declined to 2.3% of investment portfolios in 2025, down from 2.8% in 2024—marking the first year-over-year contraction in five years, according to S&P Global Market Intelligence analysis of Preqin data.
- • European insurers' private equity allocations fell more sharply, dropping to 1.8% in 2025 from 2.9% in 2024, driven by regulatory capital requirements that mandate higher reserves against risky alternative investments.
- • The pullback reflects ongoing exit challenges in private equity markets, where stalled deal exits have slowed the return of profits to institutional investors including insurance funds.
- • Despite the allocation decline, strategic ties between private equity firms and insurers have strengthened through acquisition activity, with alternative asset managers acquiring insurers to capture fee synergies and investment management opportunities.
- • European-based private equity and venture capital firms invested $6.8 billion in domestic AI companies in 2025, up 83% year-over-year, indicating sector reallocation rather than wholesale retreat from alternatives.
Summary
Insurers are reducing their exposure to private equity allocations after five consecutive years of growth, signaling investor caution amid the asset class's persistent exit challenges. According to S&P Global Market Intelligence's analysis of Preqin data, North American insurers trimmed their median private equity allocation to 2.3% of total investment portfolios in 2025, down from 2.8% in the prior year. The contraction was more pronounced in Europe, where median allocations fell to 1.8% from 2.9%—representing the steepest decline across both regions in the past five years.
The retrenchment stems primarily from private equity's exit bottleneck, which has materially slowed the return of capital and distributions to limited partners. As exit velocity decelerates and zombie fund formations persist, institutional investors face extended holding periods and delayed profit realization. Regulatory pressures compound this dynamic, particularly in Europe, where Solvency II and equivalent capital frameworks require insurers to maintain elevated capital buffers against private equity investments classified as higher-risk alternatives. These regulatory headwinds have directly constrained allocation capacity for European insurance balance sheets.
However, the pullback in allocation percentages obscures a more complex market reality. Despite declining median allocations, structural ties between private equity and insurance have deepened through strategic acquisitions. Major alternative asset managers have acquired insurance platforms to capitalize on synergies—leveraging insurance capital bases for investment management fees while providing insurers access to diversified alternative portfolios. Property and casualty insurers, benefiting from strong recent earnings, maintain substantial dry powder for capital deployment.
The reallocation trend extends into emerging opportunities within alternatives. European-based private equity and venture capital investors deployed $6.8 billion into domestic artificial intelligence companies in 2025, representing an 83% increase year-over-year. This redeployment suggests insurers and their PE partners are selectively rotating from underperforming legacy portfolios toward higher-conviction growth sectors, rather than undertaking a comprehensive retreat from alternatives. The exit challenge thus appears to be reshaping, rather than eliminating, the insurance-private equity relationship.
The retrenchment stems primarily from private equity's exit bottleneck, which has materially slowed the return of capital and distributions to limited partners. As exit velocity decelerates and zombie fund formations persist, institutional investors face extended holding periods and delayed profit realization. Regulatory pressures compound this dynamic, particularly in Europe, where Solvency II and equivalent capital frameworks require insurers to maintain elevated capital buffers against private equity investments classified as higher-risk alternatives. These regulatory headwinds have directly constrained allocation capacity for European insurance balance sheets.
However, the pullback in allocation percentages obscures a more complex market reality. Despite declining median allocations, structural ties between private equity and insurance have deepened through strategic acquisitions. Major alternative asset managers have acquired insurance platforms to capitalize on synergies—leveraging insurance capital bases for investment management fees while providing insurers access to diversified alternative portfolios. Property and casualty insurers, benefiting from strong recent earnings, maintain substantial dry powder for capital deployment.
The reallocation trend extends into emerging opportunities within alternatives. European-based private equity and venture capital investors deployed $6.8 billion into domestic artificial intelligence companies in 2025, representing an 83% increase year-over-year. This redeployment suggests insurers and their PE partners are selectively rotating from underperforming legacy portfolios toward higher-conviction growth sectors, rather than undertaking a comprehensive retreat from alternatives. The exit challenge thus appears to be reshaping, rather than eliminating, the insurance-private equity relationship.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.